Natural killer cell licensing in mice with inducible expression of MHC class I

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 45, 2013, Pages

  Ebihara, Takashi ^a   Jonsson, A Helena ^b   Yokoyama, Wayne M ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunity; Lymphocytes; Tolerance

Indexed keywords

CD69 ANTIGEN; DOXYCYCLINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR BETA; L SELECTIN; LEUKOSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR NKG2D; OVALBUMIN; TETRACYCLINE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GRANULOCYTE; HEMATOPOIETIC CELL; HOST; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SPLEEN; STROMA CELL; T LYMPHOCYTE;

IMMUNITY; LYMPHOCYTES; TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; RECEPTORS, NATURAL KILLER CELL; SPLEEN;

EID: 84887300036     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318255110     Document Type: Article

References (42)

1. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225-274.
2. Yokoyama WM (2013) Natural killer cells. Fundamental Immunology, ed Paul WE (Lippincott Williams & Wilkins, Philadelphia), 7th Ed, pp 395-431.
3. Karlhofer FM, Ribaudo RK, Yokoyama WM (1992) MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358(6381):66-70.
4. Ljunggren HG, Kärre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11(7):237-244.
5. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D (1991) MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 253(5016): 199-202.
6. Höglund P, et al. (1991) Recognition of beta 2-microglobulin- negative (beta 2m-) Tcell blasts by natural killer cells from normal but not from beta 2m- mice: Nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 88(22):10332-10336.
7. Kim S, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436(7051):709-713.
8. Fernandez NC, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105(11):4416-4423.
9. Gumperz JE, Parham P (1995) The enigma of the natural killer cell. Nature 378(6554): 245-248.
10. Kelley J, Walter L, Trowsdale J (2005) Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 1(2):129-139.
11. Anfossi N, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25(2):331-342.
12. Kim S, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 105(8):3053-3058.
13. Vivier E, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44-49.
14. Tormo J, Natarajan K, Margulies DH, Mariuzza RA (1999) Crystal structure of a lectinlike natural killer cell receptor bound to its MHC class I ligand. Nature 402(6762): 623-631.
15. Matsumoto N, Mitsuki M, Tajima K, Yokoyama WM, Yamamoto K (2001) The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med 193(2): 147-158.
16. Matsumoto N, Yokoyama WM, Kojima S, Yamamoto K (2001) The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove. J Immunol 166(7):4422-4428.
17. Wang J, et al. (2002) Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin. J Biol Chem 277(2):1433-1442.
18. Choi T, Ferris ST, Matsumoto N, Poursine-Laurent J, Yokoyama WM (2011) Ly49- dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol 186(7):3911-3917.
19. Doucey MA, et al. (2004) Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 5(3):328-336.
20. Chalifour A, et al. (2009) A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30(3):337-347.
21. Elliott JM, Wahle JA, Yokoyama WM (2010) MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 207(10):2073-2079.
22. Joncker NT, Shifrin N, Delebecque F, Raulet DH (2010) Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 207(10):2065-2072.
23. Sjöström A, et al. (2001) Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. J Exp Med 194(10):1519-1530.
24. Zimmer J, Ioannidis V, Held W (2001) H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: Implications for NK cell function. J Exp Med 194(10):1531-1539.
25. Truscott SM, et al. (2007) Disulfide bond engineering to trap peptides in the MHC class I binding groove. J Immunol 178(10):6280-6289.
26. Mitaksov V, et al. (2007) Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem Biol 14(8):909-922.
27. Zambrowicz BP, et al. (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94(8):3789-3794.
28. Kim S, et al. (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3(6):523-528.
29. Hayakawa Y, Smyth MJ (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176(3):1517-1524.
30. Raulet DH, Vance RE (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6(7):520-531.
31. Elliott JM, Yokoyama WM (2011) Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 32(8):364-372.
32. Tripathy SK, et al. (2008) Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med 205(8):1829-1841.
33. Sun JC, Lanier LL (2008) Tolerance of NK cells encountering their viral ligand during development. J Exp Med 205(8):1819-1828.
34. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu Rev Immunol 31:227-258.
35. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM (2010) Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 184(7):3424-3432.
36. Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F (1996) Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions. J Exp Med 183(4):1553-1559.
37. Held W, Mariuzza RA (2008) Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol 8(4):269-278.
38. Tarek N, et al. (2012) Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 122(9):3260-3270.
39. Jennes W, et al. (2013) Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. Blood 121(7):1157-1164.
40. Cooley S, et al. (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116(14):2411-2419.
41. McKenna DH, Kadidlo DM, Cooley S, Miller JS (2012) Clinical production and therapeutic applications of alloreactive natural killer cells. Methods Mol Biol 882:491-507.
42. Foley B, et al. (2011) NK cell education after allogeneic transplantation: Dissociation between recovery of cytokine-producing and cytotoxic functions. Blood 118(10): 2784-2792.